Biotech Values

[pcrutch]

Do you still think that patent news is consequential to the litigation, in light of the comments below? This could just be posturing and trying not to give away any strategy. thanks

"Eric – Oppenheimer:
I just had one quick question for the glatiramer acetate patent you guys were awarded a couple of days ago, could that be used to provide validation that you don't infringe upon Teva’s patents?

Craig Wheeler
I don't really think it is designed to do that, it is really designed to actually control the manufacturing process so we can actually duplicate what Teva’s made, so that is really the intents of the patents. So I think – there might be some read-through on that but I don’t think that there are lot of read-through in that direction."